The Effects of Asymmetric Dimethylarginine (Adma), Nitric Oxide (No) and Homocysteine (Hcy) On Progression of Mild Chronic Kidney Disease (Ckd) Relationship Between Clinical and Biochemical Parameters

Chronic Kidney Disease Is An Increasing Health And Economical Problem In Our World. Obesity And Diabetes Mellitus, The Two Most Common Cause Of Ckd, Are Becoming Epidemic In Our Societies. Education On Healthy Lifestyle And Diet Is Becoming More And More Important For Reducing The Number Of Type 2 Diabetics And Patients With Hypertension. Education Of Our Patients Is Also Crucial For Successful Maintenance Therapy. There Are, However, Certain Other Factors Leading To Ckd, For Instance The Genetic Predisposition In The Case Of Polycystic Kidney Disease Or Type 1 Diabetes, Where Education Alone Is Not Enough. Preface Chronic Kidney Disease......Page 1 01 ADAM Proteases as Novel Therapeutic Targets in Chronic Kidney Disease ......Page 13 02 Severity and Stages of Chronic Kidney Disease ......Page 25 03 The New Kidney and Bone Disease: Chronic Kidney Disease – Mineral and Bone Disorder (CKD–MBD) ......Page 37 04 The Prevalence of Renal Osteodystrophy in Chronic Renal Failure Patients in Urban Niger Delta of Nigeria ......Page 59 05 Relationships Among Renal Function, Bone Turnover and Periodontal Disease ......Page 85 06 Sarcoidosis and Kidney Disease ......Page 99 07 Origins of Cardiorenal Syndrome and the Cardiorenal Connection ......Page 119 08 Sub-Types and Therapeutic Management of the Cardiorenal Syndrome ......Page 135 09 Atherosclerotic Renovascular Disease ......Page 161 10 Pharmacologic Adjuvants to Reduce Erythropoietin Therapy Dose in Anemia of Chronic Kidney Disease and End Stage Renal Disease ......Page 173 11 Molecular Mechanisms of Nephro-Protective Action of HE-86 Liquid Extract in Experimental Chronic Renal Failure ......Page 187 12 The Effects of Asymmetric Dimethylarginine (ADMA), Nitric Oxide (NO) and Homocysteine (Hcy) on Progression of Mild Chronic Kidney Disease (CKD): Relationship Between Clinical and Biochemical Parameters ......Page 209 13 Neutrophil Activation and Erythrocyte Membrane Protein Composition in Stage 5 Chronic Kidney Disease Patients ......Page 221 14 Assessing Iron Status in CKD Patients: New Laboratory Parameters ......Page 237 15 Exogenous Fluorescent Agents for the Determination of Glomerular Filtration Rate ......Page 263 16 Modern Surgical Treatments of Urinary Tract Obstruction ......Page 273 17 Extra-Anatomic Urinary Drainage for Urinary Obstruction ......Page 293 18 Percutaneous Nephrostomy ......Page 309 19 Unusual Vascular Access for Hemodialysis Therapies ......Page 327 20 The Role of Nephron-Sparing Surgery (NSS) for Renal Tumours >4 cm ......Page 341 21 Benign Prostate Hyperplasia and Chronic Kidney Disease ......Page 359 22 Asymptomatic Bacteriuria (ASB), Renal Function and Hypertension ......Page 389 23 Sleep Disorders Associated with Chronic Kidney Disease ......Page 397 24 The Allo-Immunological Injury in Chronic Allograft Nephropathy ......Page 413 25 Prevention and Regression of Chronic Kidney Disease and Hypertension ......Page 427 26 Health-Related Quality of Life in Chronic Renal Predialysis Patients Exposed to a Prevention Program – Medellín, 2007-2008 ......Page 443